KERRY CLARK: Open Payments
NPI 1932575743 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 62 payments from 20 companies in 2025. Trend: 2023 $864 · 2024 $851 · 2025 $1,458
Food & beverage: $1,427Education: $30
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $302 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $159 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| Ethicon US, LLC | 1 | $130 |
| ABBVIE INC. | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
| Ardelyx, Inc. | 5 | $82 |
| GENZYME CORPORATION | 3 | $74 |
| PFIZER INC. | 3 | $62 |
| Ipsen Biopharmaceuticals, Inc | 2 | $52 |
Products named: TREMFYA, XIFAXAN, LINX REFLUX MANAGEMENT SYSTEM, DUPIXENT, IBSRELA, ENTYVIO, IQIRVO, VELSIPITY.
Industry payments across VA — which companies pay providers there.
